ALIM - ALIMERA SCIENCES INC

QQQ $ 481.88 $ 1.99 (0.41 %)

DIA $ 391.49 $ 0.65 (0.17 %)

SPY $ 544.89 $ 1.15 (0.21 %)

TLT $ 90.79 $ 0.12 (0.13 %)

GLD $ 215.48 $ 0.21 (0.1 %)

Previous Close

$ 5.52

Open

$ 5.55

Bid

$ 5.51 x 100

Ask

$ 5.57 x 154

Day's Range

$ 5.52 - $ 5.55

52 Week Range

$ 2.60 - $ 5.65

Volume

260,428

Average Volume

Market Cap

300.05M

Beta (5Y Monthly)

$ 1.31

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-14-2024	03-31-2024	10-Q
2	03-08-2024	12-31-2023	10-K
3	11-02-2023	09-30-2023	10-Q
4	08-11-2023	06-30-2023	10-Q
5	05-15-2023	03-31-2023	10-Q
6	03-31-2023	12-31-2022	10-K
7	11-14-2022	09-30-2022	10-Q
8	08-05-2022	06-30-2022	10-Q
9	05-12-2022	03-31-2022	10-Q
10	03-23-2022	12-31-2021	10-K
11	11-05-2021	09-30-2021	10-Q
12	08-16-2021	06-30-2021	10-Q
13	05-07-2021	03-31-2021	10-Q
14	03-05-2021	12-31-2020	10-K
15	11-03-2020	09-30-2020	10-Q
16	08-04-2020	06-30-2020	10-Q
17	05-06-2020	03-31-2020	10-Q
18	03-02-2020	12-31-2019	10-K
19	11-05-2019	09-30-2019	10-Q
20	08-06-2019	06-30-2019	10-Q
21	05-07-2019	03-31-2019	10-Q
22	02-25-2019	12-31-2018	10-K
23	11-09-2018	09-30-2018	10-Q
24	08-02-2018	06-30-2018	10-Q
25	05-09-2018	03-31-2018	10-Q
26	03-02-2018	12-31-2017	10-K
27	11-03-2017	09-30-2017	10-Q
28	08-10-2017	06-30-2017	10-Q
29	05-11-2017	03-31-2017	10-Q
30	03-03-2017	12-31-2016	10-K
31	11-04-2016	09-30-2016	10-Q
32	08-05-2016	06-30-2016	10-Q
33	05-06-2016	03-31-2016	10-Q
34	03-15-2016	12-31-2015	10-K
35	11-09-2015	09-30-2015	10-Q
36	08-10-2015	06-30-2015	10-Q
37	05-11-2015	03-31-2015	10-Q
38	03-13-2015	12-31-2014	10-K
39	11-14-2014	09-30-2014	10-Q
40	08-11-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Alliance Global Partners Downgrades Alimer...
06/25/2024 15:17:40

Alliance Global Partners analyst James Molloy downgrades Alimera Sciences (NASDAQ:ALIM) from Buy to Neutral.

Maxim Group Downgrades Alimera Sciences to...
06/25/2024 12:47:55

Maxim Group analyst Naz Rahman downgrades Alimera Sciences (NASDAQ:ALIM) from Buy to Hold.

HC Wainwright & Co. Downgrades Alimera Sci...
06/25/2024 11:07:45

HC Wainwright & Co. analyst Yi Chen downgrades Alimera Sciences (NASDAQ:ALIM) from Buy to Neutral and maintains $6 price...

nasdaq-records-worst-session-since-april-with-nvidia-plunging-7-dow-jones-sees-modest-gains-amid-mixed-market-close

Nasdaq Records Worst Session Since April W...
06/25/2024 06:45:26

dow-jumps-300-points-alimera-sciences-shares-spike-higher

Dow Jumps 300 Points; Alimera Sciences Sha...
06/24/2024 17:06:48

generics-player-ani-pharmaceuticals-strengthens-rare-disease-segment-with-380m-alimera-sciences-deal

Generics Player ANI Pharmaceuticals Streng...
06/24/2024 15:28:28

ANI Pharmaceuticals to acquire Alimera Sciences for $5.50 per share in cash, plus a contingent value right of up to $0.50 per s...

ANI Pharma to Snap Alimera Sciences Valuin...
06/24/2024 10:55:27

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) ("ANI" or the "Company") and Alimera Sciences, Inc. (NASDAQ:ALIM) ("...

HC Wainwright & Co. Reiterates Buy on Alim...
05/16/2024 11:08:28

HC Wainwright & Co. analyst Yi Chen reiterates Alimera Sciences (NASDAQ:ALIM) with a Buy and maintains $6 price target.

Alimera Sciences Q1 EPS $(0.12) Misses $(0...
05/14/2024 11:35:07

Alimera Sciences (NASDAQ:ALIM) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(...

Alimera Announces Scientific Data Highligh...
05/07/2024 12:11:28

Alimera Sciences, Inc. (NASDAQ:ALIM) ("Alimera"), a global pharmaceutical company whose mission is to be invaluable to ...

Maxim Group Initiates Coverage On Alimera ...
03/25/2024 12:03:50

Maxim Group analyst Naz Rahman initiates coverage on Alimera Sciences (NASDAQ:ALIM) with a Buy rating and announces Price Ta...

Alimera Announces First Patient Randomized...
03/19/2024 12:05:42

HC Wainwright & Co. Maintains Buy on Alime...
03/08/2024 18:01:12

HC Wainwright & Co. analyst Yi Chen maintains Alimera Sciences (NASDAQ:ALIM) with a Buy and raises the price target from...

Alimera Sciences Expects 2024 Revenue Over...
03/07/2024 12:40:40

Alimera Sciences Q4 EPS $(0.07) Up From $(...
03/07/2024 12:32:27

Alimera Sciences (NASDAQ:ALIM) reported quarterly losses of $(0.07) per share. This is a 87.04 percent increase over losses of ...

Earnings Scheduled For March 7, 2024
03/07/2024 09:49:44

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on rev...

A Preview Of Alimera Sciences's Earnings
03/06/2024 19:02:04

The UK National Institute For Health And C...
02/08/2024 13:01:52

Alimera Sciences, Inc. (NASDAQ:ALIM) ("Alimera"), a global pharmaceutical company whose mission is to be invaluable to ...

Alimera Completes Recruitment For The Sync...
01/04/2024 13:15:16

Alimera Sciences, Inc. (NASDAQ:ALIM) ("Alimera"), a global pharmaceutical company whose mission is to be invaluable to ...

Alimera Sciences Appoints Elliot Maltz As ...
01/02/2024 13:12:14

CLASS ACTION DEADLINES - JOIN NOW!

07/02/2024 Intel Corporation (INTC)

07/05/2024 AXT, Inc. (AXTI)

07/05/2024 Altimmune, Inc. (ALT)

07/09/2024 Li Auto Inc. (LI)

07/12/2024 Inari Medical, Inc. (NARI)

07/12/2024 Sprout Social, Inc. (SPT)

07/15/2024 UnitedHealth Group Inc. (UNH)

07/16/2024 Teladoc Health, Inc. (TDOC)

07/16/2024 Vestis Corporation (VSTS)

07/22/2024 Cambium Networks Corporation (CMBM)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)

ALIMALIMERA SCIENCES INC

Nasdaq alimerasciences.com

$ 5.53 $ -0.04 (-0.72 %)

Monday, 01-Jul-2024 15:59:32 EDT